Matches in Wikidata for { <http://www.wikidata.org/entity/Q73900850> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q73900850 description "artículu científicu espublizáu en xunu de 2000" @default.
- Q73900850 description "im Juni 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73900850 description "scientific article published on 01 June 2000" @default.
- Q73900850 description "wetenschappelijk artikel" @default.
- Q73900850 description "наукова стаття, опублікована в червні 2000" @default.
- Q73900850 name "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 name "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 type Item @default.
- Q73900850 label "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 label "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 prefLabel "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 prefLabel "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 P1433 Q73900850-5A5165A6-8CD9-44B1-9F9E-8300C42C9EDF @default.
- Q73900850 P1476 Q73900850-BB4A6452-5766-4170-A4D4-DFA0E5012968 @default.
- Q73900850 P2093 Q73900850-07A4200A-3D0F-45D2-B4F6-6A873EE384D1 @default.
- Q73900850 P2093 Q73900850-0A947E32-452C-448A-91EC-EF3620CF93BE @default.
- Q73900850 P2093 Q73900850-1A1336B3-1A30-4D2E-99CF-FAF18EB8BC0E @default.
- Q73900850 P2093 Q73900850-44AA6364-CEC0-4F42-99E9-3EB5648BB684 @default.
- Q73900850 P2093 Q73900850-6F5EF6F5-6331-4B7D-B1A9-C596C9EF617D @default.
- Q73900850 P2093 Q73900850-ADB39B6E-E829-4DA1-9FA8-13A2B89354EC @default.
- Q73900850 P304 Q73900850-AAE668F5-5BA1-40C2-9D1A-50BB892AF978 @default.
- Q73900850 P31 Q73900850-6D198165-84A1-4B82-B6C5-1E024B5F0F36 @default.
- Q73900850 P356 Q73900850-7E2DF597-482D-4527-9727-9BFCF70384E8 @default.
- Q73900850 P407 Q73900850-44B4F423-2BC4-4C8B-9135-141104BF0D71 @default.
- Q73900850 P433 Q73900850-43801EB6-8A6C-4358-8D51-8CC2F23F2C06 @default.
- Q73900850 P478 Q73900850-CEE696E7-74B0-42DD-AF03-9D28216C84DF @default.
- Q73900850 P577 Q73900850-7BEC2763-D038-4291-B299-2BBF4853F5FF @default.
- Q73900850 P698 Q73900850-33B34F52-A2F4-4DE4-8FCF-B23E181B9200 @default.
- Q73900850 P921 Q73900850-B6006936-3921-4F0B-A849-07FC212D218E @default.
- Q73900850 P921 Q73900850-B78E1C79-29F4-47E5-BCD0-91E7D1EA3A19 @default.
- Q73900850 P356 JCO.2000.18.12.2419 @default.
- Q73900850 P698 10856102 @default.
- Q73900850 P1433 Q400292 @default.
- Q73900850 P1476 "Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer" @default.
- Q73900850 P2093 "B I Rini" @default.
- Q73900850 P2093 "D A Taber" @default.
- Q73900850 P2093 "J L Wade" @default.
- Q73900850 P2093 "M C Dumas" @default.
- Q73900850 P2093 "N J Vogelzang" @default.
- Q73900850 P2093 "W M Stadler" @default.
- Q73900850 P304 "2419-2426" @default.
- Q73900850 P31 Q13442814 @default.
- Q73900850 P356 "10.1200/JCO.2000.18.12.2419" @default.
- Q73900850 P407 Q1860 @default.
- Q73900850 P433 "12" @default.
- Q73900850 P478 "18" @default.
- Q73900850 P577 "2000-06-01T00:00:00Z" @default.
- Q73900850 P698 "10856102" @default.
- Q73900850 P921 Q238512 @default.
- Q73900850 P921 Q42824440 @default.